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Smooth Muscle Cell Mitochondrial Respiration – Effects of Aerobic Training and  
Type I Diabetes 
 Dana-Rae Reguis Yadao  
 
Cardiovascular disease is the leading cause of death among diabetic patients, due mostly to 
mitochondrial dysfunction and resulting oxidative stress. Endurance exercise has been firmly 
established as a way to reduce diabetes and cardiovascular disease morbidity and mortality. The 
importance of mitochondria for both training performance and health underlies the significance of 
better understanding the factors that regulate exercise-induced adaptations in mitochondrial 
network dynamics. The effects on mitochondrial skeletal and cardiac muscle have already been 
well documented in the past. However, the specific impact of aerobic training on respiratory 
capacity in the vasculature remain to be established. Furthermore, the relationship between aerobic 
exercise and mitochondrial function in diabetic patients has yet to be investigated. We hypothesized 
that a long-term aerobic exercise intervention would enhance mitochondrial respiratory capacity in 
vascular smooth muscle cells. First, we investigated the effects of training in the vasculature of 
healthy mice (C57BL/6) and compared them to their sedentary counterparts. We found that 
exercise stimulates a rise in vascular mitochondrial content and respiratory capacity, especially 
complex I respiration (p < 0.05). However, when comparing diabetic trained mice to diabetic 
sedentary controls, it was found that aerobic training induced a downregulation in mitochondrial 
protein expression as well as a decrease in complex I respiration. In these experiments, our findings 
suggest that despite the demonstrated benefits of exercise, careful measures should be taken when 
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Pathophysiology of Diabetes Mellitus 
Diabetes mellitus is a metabolic disease that is one of the leading causes of death worldwide 
[American Diabetes Association, 2010]. It is estimated that 193 million individuals globally remain 
undiagnosed, which consequently increases their risk of developing severe complications of 
untreated diabetes [American Diabetes Association, 2010]. Currently, 11 million Canadians are 
living with diabetes and the prevalence is expected to rise to more than one in three by the year 
2020 [Diabetes Canada, 2017]. All diabetes-related complications cost the Canadian healthcare 
system $11.7 billion in 2010, an expenditure projected to rise [Diabetes Canada, 2017]. 
 
Diabetes mellitus (DM) is classified into different categories, with Types I and II being the most 
common. All types of diabetes, though different in etiology, are characterized by chronic 
hyperglycemia [American Diabetes Association, 2010]. Type I diabetes (T1DM) is most often 
caused by an autoimmune process or a trauma that destroys the insulin-producing ß-cells in the 
pancreas, resulting in a lack of insulin [Matough, 2012]. T1DM is regarded as the more severe 
form of diabetes, as the disease typically begins at a young age with intensive daily self-
management and exogenous insulin therapy required for effective glucose control and better quality 
of life [Peasgood et al., 2016]. Consequently, poorly regulated T1DM can lead to life-threatening 
acute metabolic complications such as hypoglycemia and diabetic ketoacidosis (DKA) [Ceriello, 
2003; Peasgood et al., 2016]. Type II diabetes mellitus (T2DM) is the more prevalent form of 
diabetes, representing up to 90% of all cases [Diabetes Canada, 2017]. T2DM is triggered by 
peripheral insulin resistance and impaired fasting glucose due to a combination of genetic and 
lifestyle factors, namely overnutrition and physical inactivity [Hu, 2001]. Common risk factors for 
the development of T2DM include hypertension, lipid concentrations and impaired fasting glucose 
[American Diabetes Association, 2010]. As such, T2DM is generally managed by patients through 
careful meal planning, regular physical activity and medications [Diabetes Canada, 2017].  
 
Despite their differences in etiology, both T1DM and T2DM result in chronic hyperglycemia with 
subsequent abnormal changes in the metabolism of macronutrients [Matough, 2012].  Studies on 
the adverse effects of diabetes on specific tissues are extensive, especially in skeletal muscle given 
that it is the largest site for glucose uptake, namely through the action of transport proteins GLUT1 
and GLUT4 [DeFronzo et al., 1981]. In T1DM specifically, impaired translocation and activation 
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of glucose transporters, particularly GLUT4, was observed in the vastus lateralis muscle [Kahn et 
al., 1992]. Moreover, insulin delivery to skeletal muscles are decreased in diabetes, with myopathy 
recognized as a severe complication [D’Souza, 2013; Hernández-Ochoa et al., 2017]. With respect 
to cardiac muscle, myocardial performance is impaired via a reduced capacity for glucose transport, 
indicating a greater risk of diabetic cardiomyopathy and related cases of cardiovascular mortality 
[Rodrigues, 1998; Stanley, 1997]. Overall, the common co-morbidities of poorly regulated diabetes 
include neuropathy, nephropathy, vision disorders and cardiovascular disease [Ceriello, 2003]. 
T1DM, however, is considered the more severe form of diabetes as patients have a reduced  life 
span due to hyperglycemia-induced cardiovascular disease and acute metabolic complications 
secondary to exogenous insulin therapy, specifically life-threatening ketoacidosis [Warnes et al., 
2018]. Moreover, patients with T1DM often endure  irreversible changes leading to long-term 
health issues as the disease most often occurs in childhood or adolescence, a period where growth 
is critical [Mozdziak, 2000]. Despite advancements in the treatment of diabetes, cardiovascular 
disease is leading cause of mortality among all diabetic patients [Cai, 2001]. Consequently, 80% 
of Canadians with diabetes will die of myocardial infarction or stroke [Stehouwer, 1997; Diabetes 
Canada, 2017]. 
 
Diabetes and the Vasculature 
Nearly all tissues depend on a blood supply, which in turn depends on endothelial cells. Endothelial 
cells make up the innermost lining of blood cells and have the ability to directly detect changes in 
the blood, such as O2 availability, pH, shear stress and levels of inflammation [Alberts, 2002]. The 
endothelium produce and release a variety of vasoactive substances that act on surrounding layers 
of the blood vessel, namely vascular smooth muscle, in order to maintain regulation of vascular 
homeostasis [Hu et al., 2018]. Vascular smooth muscle cells provide vasoactive control as well as 
structural integrity through the action of contractile proteins [Metz et al., 2012]. Disturbances to 
endothelial properties may lead to alterations in permeability, vascular tone and cell-matrix 
interactions [Stehouwer, 1997]. When the endothelium loses its’ capacity to properly detect 
changes in the vascular environment and relay signals to vascular smooth muscle cells, endothelial 
dysfunction ensues, leading to the development of cardiovascular complications [Hu et al., 2018]. 
The impaired metabolism of glucose and insulin during the diabetic state is involved in endothelial 
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dysfunction, which is an early marker of damage to blood vessels. [Ceriello, 2003; Schalkwijk, 
2005].  
 
Diabetes-induced hyperglycemia is closely linked to the progression of endothelial dysfunction, 
resulting in coronary heart disease, peripheral arterial disease, diabetic nephropathy, neuropathy 
and retinopathy [Giacco, 2010; Hu et al., 2018]. Changes in the microvasculature (e.g. capillaries) 
include the synthesis of extracellular matrix proteins and expansion of the capillary basement 
membrane, which are key features of diabetic microangiopathy [Scheede-Bergdahl, 2014; Chawla, 
2016]. Microvascular complications also lead to retinopathy, nephropathy and peripheral 
neuropathy, with blindness and renal failure as major consequences [Cade, 2008; Stehouwer, 
1997]. The progression of macrovascular (e.g. arteries and veins) complications is indicated by an 
accelerated form of atherosclerosis, thus increasing the risk of ischemic heart disease, stroke and 
myocardial infarction [Cade, 2008; Brownlee, 2005].  
 
Various theories have been proposed to explain how endothelial cells exposed to high glucose can 
cause extensive structural and metabolic changes to the cardiovascular system. Many hypotheses 
focus on the dysregulation of intracellular metabolism of glucose [Brownlee, 2005]. Consequently, 
the function of vascular cells is significantly altered through various pathways, which will be 
elaborated in upcoming sections. In brief, all of these pathways are manifestations of a single 
phenomenon: oxidative stress [Cade, 2008]. Therefore, mitochondrial dysfunction, when derived 
from chronic hyperglycemia, is the primary mediator in the progression of vascular damage in 
diabetic patients [Ceriello, 2003]. 
 
Mitochondria  
Mitochondria make up a significant portion of the cytoplasmic volume in nearly all living 
eukaryotic cells and is the primary site of ATP production. [Chiong et al., 2014; Alberts et al., 
2002]. Mitochondria carry out several important tasks including the production of reactive oxygen 
species (ROS), contractile function, calcium signaling and apoptosis programming [Knaub et al., 
2014]. ATP is produced through oxidative phosphorylation, the process by which substrates 
derived from glucose and fatty acids via glycolysis and beta oxidation are metabolized, resulting 
in Acetyl-coenzyme A [Alberts et al., 2002]. Next, a series of redox reafdctions in the tricarboxylic 
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acid cycle occurs to form high-energy molecules NADH and FADH2, which then carry electrons 
to mitochondrial complexes I and II respectively, with parallel proton transfer outward from the 
intermembrane space to complex I, III and IV (Fig. 1) [Alberts et al., 2006]. This is offset by proton 
transfer in the opposite direction, known as proton leak [Sivitz and Yorek, 2010]. The resulting 
potential difference ultimately drives ADP phosphorylation to ATP via complex V [Duchen, 2004].  
 
Figure 1: Summary of oxidative phosphorylation for ATP production by substrate metabolism 
Pyruvate and fatty acids derived 
from glycolysis and beta-oxidation 
enter the mitochondrion (bottom) 
and produce acetyl CoA, which 
enters the citric acid cycle and 
allows for the reduction of NAD+ to 
NADH, a high-energy molecule that 
serves as an electron carrier. 
Electrons are transferred along the 
electron-transport chain to O2, and 
generates a proton gradient across 
the inner membrane, thus driving 
the production of ATP via ATP 
synthase [Alberts et al., 2002]. 
 
ATP is essential to sustain growth, metabolism and reproduction [Duchen, 2004]. As such, nearly 
all living cells rely on ATP for their survival. Mitochondrial function can be affected by several 
factors, such as respiratory capacity, generation and detoxification of ROS as well as regulation of 
mitochondrial matrix calcium, with abnormalities in any of these linked to dysfunction. However, 
given that the predominant physiological function of mitochondria is the production of ATP, 
impaired respiratory capacity and oxygen consumption are generally considered determinants of 
dysfunction. Given the importance of these organelles in mediating nearly all cellular processes, 
strong emphasis is placed on understanding mitochondrial function and the pathogenic processes 
involved in disease and ageing. The centrality of mitochondrial dysfunction in a wide range of 
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major diseases is becoming the focus of many epidemiological studies, thus highlighting the 
prospect of novel therapeutic approaches to treat a multitude of highly prevalent diseases [Duchen, 
2004]. 
 
Mitochondrial Dysfunction and Diabetes 
Mitochondrial respiration is a predominant source of reactive oxygen species (ROS), which are 
toxic agents derived from molecular oxygen (O2) [Addabbo, 2009; Liochev, 2013]. ROS 
generation is important because it contributes to mitochondrial dysfunction and subsequent 
oxidative damage seen in various pathologies [Murphy, 2009]. For instance, excessive ROS 
production is one of the driving forces of insulin resistance and increased lipid accumulation in 
skeletal muscle [Petersen et al., 2003]. As a predominant site for energy production, it is not 
surprising that mitochondria are involved in many aspects of diabetes, including etiology, 
complications, management and prevention. Indeed, the relationship between insulin resistance 
and mitochondrial function is complex and is characterized by a decrease in mitochondrial ATP 
production, lowered mitochondria RNA and reduced oxidative phosphorylation [Petersen et al., 
2003]. While mitochondrial function is generally assessed by respiratory capacity, it is also 
important to note that evidence exists that the metabolic disease is also responsible for causing 
defects in mitochondrial biogenesis, number, morphology, fusion and fission [Sivitz and Yorek, 
2010].  
 
Figure 2: Mitochondrial dysfunction and disease as 
consequences of excessive ROS production  
Mitochondrial dysfunction is linked to ROS production, 
which causes damage to proteins, DNA and activates 
cell death via the release of intermembrane space 
proteins such as cytochrome c (cyt c). While low levels 
of ROS can contribute to regulating biological and 
physiological processes via redox signalling, excessive 
ROS can lead to a variety of pathologies related to 
mitochondrial dysfunction and apoptosis/necrosis,         




Greater degrees of oxidative stress and respiratory incapacities occur in diabetes, which promotes 
abnormal gene expression, altered cell signalling and the activation of pathways leading to cell 
death [Cai, 2001]. While this can result from several mechanisms, abnormal mitochondrial 
respiration plays a key role [Panth, 2016]. In hyperglycemic states, endothelial cells are unable to 
efficiently control glucose transport compared to other cells, making them susceptible to oxidative-
induced damage [Ceriello, 2003]. The mitochondria are consequently supplied by a greater flux of 
glycolysis-derived pyruvate to the tricarboxylic acid cycle [Giacco, 2010]. This creates an overload 
of electron donors, driving the mitochondrial membrane potential upwards, which subsequently 
increases ROS generation at the complex II level in the respiratory chain [Bajaj, 2012].  
 
Mitochondrial Pathways Leading to Vascular Complications 
When endothelial cells are exposed to high glucose levels, the overproduction of ROS by the 
mitochondria triggers the activation of four specific pathways underlying the development of 
vascular complications: activation of protein kinase C (PKC); increased advanced glycation end-
product (AGE) formation; and greater glucose flux both through both the polyol and hexosamine 
pathways [Giacco, 2010].    
 
Firstly, the chronic activation of PKC leads to vascular disturbances such as increased permeability, 
contractility and cell death [Geraldes, 2011]. The changes caused by PKC activation are linked to 
the development of atherosclerosis and cardiomyopathy [Geraldes, 2011].  Secondly, AGE form as 
a result of a process known as protein glycation, where glucose molecules and plasma proteins 
form irreversible covalent bonds [Singh, 2014]. This process promotes the pro-inflammatory 
response as well as interferes with normal molecular conformation and receptor functioning, which 
in turn can lead to neuropathy, nephropathy and cardiomyopathy [Scheede-Bergdahl, 2004; Singh, 
2011]. Increased formation of AGE leads to greater ROS generation and can deactivate local 
antioxidant systems [Sugimoto, 2008]. AGE’s also induce microvascular disease through the 
expansion of the capillary basement membrane (CBM) [Scheede-Bergdahl, 2014]. Thirdly, an 
increased glucose flux into the polyol pathway results in the accumulation of ROS in the tissues, 
including the heart and vasculature [Tang 2012]. Finally, an overload of glucose into the 
hexosamine pathway inhibits endothelial nitric oxide synthase (eNOS), which is crucial in 
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maintaining vascular tone [Giacco, 2010]. Therefore, the continuous production of ROS in 
endothelial cells exposed to high glucose has deleterious effects on the vasculature and thus 
significantly increases the risk for cardiovascular disease. 
 
Complications linked with abnormal mitochondrial respiration and oxidative stress are not limited 
to the vasculature. Skeletal and cardiac muscles are also negatively affected by the same pathways 
that damage the vasculature in diabetes. Much research has already been done to explore the topic 
of diabetes-induced cardiomyopathy, with leading theories based on altered energy metabolism 
resulting in mitochondrial dysfunction within the myocytes [Brahma, 2017]. One study concluded 
that mitochondrial dysfunction defined by a reduction in complex III activity in the electron 
transport chain resulted in increased ROS generation and damage to cardiomyocytes [Suematsu et 
al., 2003]. Further, impaired muscle force output, greater fatigue rates and reduced local blood flow 
occur due to excessive ROS production [Kelley, 2002]. Another study found that decreased 
mitochondrial respiratory capacity, reduced ATP synthesis and greater ROS production lead to 
skeletal muscle insulin resistance and subsequent T2DM [Pagel-Langenickel et al., 2010]. Thus, 
mitochondrial dysfunction underlies all the major pathogenic pathways leading to diabetic 




Figure 3        Figure 3 : Hyperglycemia-induced diabetic 
complications begin at the mitochondrial level 
with the activation of four pathways: chronic 
activation of protein kinase C (PKC), AGE 
formation, and increased glucose flux into both 
the polyol and hexosamine pathways. This process 
causes endothelial dysfunction, ultimately leading 
to diabetes-specific vascular complications 
[Adapted  from Ceriello, 2003].  
 







Exercise and Diabetes 
Oxidative stress occurs continuously as part of metabolic processes, including the contraction of 
skeletal muscles during exercise, where a greater amount of oxygen is required to produce ATP 
[Lobo, 2010]. As mentioned previously, ROS triggers oxidative reactions with proteins, lipids and 
DNA, thus leading to detrimental effects. In contrast to the prolonged oxidative stress that occurs 
in diabetes, an acute and normal increase in free radical generation is observed during exercise 
[Urso, 2003]. Predominant sources of ROS in the muscle are produced by the mitochondria, 
specifically through a leak of single electrons leading to the generation of superoxide (O2•-) 
[Steinbacher, 2015]. It is generally accepted that exercise promotes low-to-moderate levels of ROS, 
which can have some benefits, including regulation of cell signaling and skeletal muscle force 
production [Powers, 2008]. It has been reported that the human body can effectively regulate 
exercise-induced oxidative stress, with previous studies suggesting that a modest increase in ROS 
can facilitate muscle adaptation [Jackson, 1999]. This regulation is due in part to the activation of 
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endogenous antioxidant systems and their ability to adequately prevent oxidative stress [Powers, 
2008].  
 
Exercise has long been understood to provide many health-promoting benefits for people and 
without diabetes. Indeed, long-term physical activity is encouraged by therapists as a non-
pharmacological approach to effectively regulate diabetes-related health issues. The goals of 
exercise therapy for patients with diabetes include the reduction of hyperglycemia, insulin 
resistance, dyslipidemia and hypertension, all of which translate into a lower risk of vascular 
disease in children, adolescents and adults [Sato et al., 2007]. With regards to T1DM specifically, 
special considerations are made for the pediatric population, with difficulties adhering to a strict 
diabetes regimen as a common setback [Silverstein et al., 2005]. Endurance exercise in particular 
has been firmly established as a way to reduce diabetic complications and cardiovascular disease 
morbidity and mortality. However, existing data regarding the effects of exercise training in T1DM 
patients are far less extensive than it is for T2DM patients. Strong evidence shows that both aerobic 
and resistance exercise can improve insulin action, and therefore promote glucose uptake into local 
tissues in T2DM [Colberg, 2010]. One study found that endurance training stimulated an increase 
in VO2max in patients with T2DM, accompanied by an increase in both mitochondrial content and 
function [Phielix et al., 2010]. This is essential as mitochondrial dysfunction is heavily implicated 
in the pathophysiology of disease such as diabetes. In cardiac muscle, increased substrate 
metabolism and enhanced mitochondrial dynamics within myocytes have been reported. However, 
significant increases in ROS during aging and/or disease can cause contractile impairments and 
muscle atrophy, which in turn can lead to muscle weakness and fatigue [Steinbacher, 2015].   
 
Given the beneficial effects of exercise on the cardiovascular system and the evidence that T1DM 
patients present a higher risk of developing vascular complications, an exercise program specific 
to reducing the risk factors for cardiovascular disease at the level of vascular smooth muscle 
would be valuable. More importantly, there is a need to investigate the effects of aerobic exercise 
on mitochondrial function of the vasculature, considering that the mitochondria is deeply 






Cardiovascular disease as the leading cause of mortality among the diabetic population. The 
benefits of regular physical activity on diabetes and cardiovascular disease are firmly established. 
However, the risk for mitochondria-mediated vascular diseases remains significant, even in the 
presence of rigorous glycemic control, including diet and exercise. It was recently reported that 
impaired mitochondrial function in the context of reduced ATP synthesis in T2DM patients also 
extends to metabolically well-controlled patients [Szendroedi et al., 2007]. Indeed, mitochondrial 
dysfunction is considered to be critically involved in the pathophysiology of diabetes, and exercise 
has been regarded as a way to stimulate favourable adaptations such as mitochondrial biogenesis 
and enhanced respiratory capacity. 
Despite evidence affirming the role of exercise in stimulating enhanced mitochondrial dynamics in 
skeletal and cardiac muscle, surprisingly little is known about the vasculature. The main objective 
of this thesis is to provide novel insight on the specific impact of aerobic training on mitochondrial 
respiratory capacity in both healthy and untreated T1DM vessels. Existing data on oxidative 
capacity of vascular smooth muscle cells in response to training is limited. In our first experiment, 
we hypothesized that exercise will promote mitochondrial respiration in the vasculature of healthy 
mice. Next, in a separate study, we examined the same relationship in streptozotocin-induced 
T1DM mice. We hypothesized that exercise would improve mitochondrial respiration of vascular 
smooth muscle cells in untreated T1DM mice in response to training. Following an aerobic exercise 
programme over four weeks, respiratory capacity will be assessed in permeabilized and intact aortic 
vessels from mice. Immunoblotting will determine mitochondrial content and relative protein 
levels. High-resolution respirometry will allow us to examine each mitochondrial complex as well 
as determine the efficiency of oxidative phosphorylation based on oxygen consumption of different 
respiration states.  
Diabetes is quickly becoming one of the biggest health epidemics of the 21st century. The rise in 
the incidence of metabolic diseases worldwide has driven scientific research with the aim of 
identifying new adjunct therapy for both T1DM and T2DM. Together with the findings outlined in 
our review paper on the efficacy of selectively reducing branched-chain amino acid intake in 
reducing metabolic complications of obesity and T2DM, this thesis can contribute to current 
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research in identifying new molecular targets that may prove amenable to therapies addressing 
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Mitochondria are the primary site of ATP production, and its’ function is heavily implicated in 
cardiovascular disease and metabolic disorders such as diabetes. Exercise-induced mitochondrial 
adaptations include enhanced network morphology, increased protein expression and augmented 
respiratory capacity, all of which are strongly correlated with greater substrate oxidation, energy 
metabolism and overall training performance. Thus, the opportunities for effective exercise therapy 
interventions are significant. To date, most studies examining the relationship between 
mitochondrial network dynamics and exercise have focused largely on skeletal and cardiac muscle. 
As a result, little has been reported on mitochondrial respiratory capacity in the vasculature, 
specifically in response to chronic exercise. We hypothesized that a 4-week aerobic training 
intervention in mice would elicit greater vascular oxidative capacity compared to sedentary 
counterparts. After performing high-resolution respirometry in aortic vessels, we found that the 
trained mice group exhibited a significant increase in the respiration of complex I-linked, glucose-
based substrates (p<0.05). Additionally, immunoblotting demonstrated a trend towards 
upregulation in relative mitochondrial protein expression in all complexes (I-V) as well as in 
mitochondrial density. Understanding the importance of exercise-induced mitochondrial 
adaptations in the vasculature is vital to developing new therapeutic treatments of vascular diseases 












Mitochondria are important organelles that make up approximately 10% of the human body weight 
and carry out a variety of cellular functions necessary to sustain growth, metabolism and 
reproduction [Duchen, 2004; Park et al., 2014]. Mitochondria are also involved in the generation 
of reactive oxygen species (ROS), contractile function, calcium signaling and apoptosis 
programming [Knaub et al., 2014]. However, its’ best-known role is the production of ATP via 
mitochondrial respiration. The importance of mitochondria in mediating nearly all cellular 
processes underlies the premise that mitochondrial function is central in understanding the 
pathogenic processes of various diseases. Indeed, poor oxidative capacity due to a decline in 
mitochondrial content and function is associated with aging, insulin resistance and diabetes 
[Menshikova, 2006].  
 
While mitochondria are found in nearly all cells of the body, they have different implications in 
different tissues, and their capacities vary depending on certain metabolic demands. For instance, 
mitochondria found in cardiac muscle represent approximately 35% of the total tissue volume, 
compared to only 4-7% in skeletal muscle [Stride et al., 2013]. Cardiomyocytes contain a 
particularly high concentration of mitochondria to continuously provide energy supplies needed 
for oxygen transport, even producing up to 90% of ATP by beta-oxidation at rest [Song et al., 
2014]. For skeletal muscle, the ATP requirement during exercise increases dramatically to allow 
for contraction and locomotion. Despite their differences in mitochondrial content, the increased 
metabolic demands of exercise require both the cardiovascular and musculoskeletal systems to 
work together, and the mitochondria within each distinct muscle respond similarly. The efficiency 
of cardiac, skeletal and vascular smooth muscle to perform cellular respiration determines 
performance during exercise [Park et al., 2014].   
 
Mitochondria undergo extensive biochemical and morphological adaptations in response to 
exercise training. These changes are correlated with improved oxidative capacity and metabolism, 
both of which are considered determinants for enhanced performance. Mitochondrial function can 
be assessed by measuring state 3 respiration (oxygen consumption activated by ADP) and the 
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respiratory control ratio (RCR), which is the ratio of state 3 to state 4 respiration and provides an 
index of mitochondrial coupling as well as the efficiency of ATP formation during complex I+II 
respiration [Madsen et al., 1996; Sivitz and Yorek, 2010]. Generally, a reduction in RCR is 
associated with mitochondrial dysfunction and inefficiency [Boudina et al., 2007]. One study 
demonstrated an increase in RCR due to an increase in state 3 respiration in cardiac mitochondria 
following prolonged exercise [Madsen et al., 1996]. Another study highlighted the importance of 
endurance exercise in the protection of the heart against cardiac injury based on the modulating 
effects of mitochondria [Ascensão et al., 2006]. With regards to skeletal muscle, lower fatigue rates 
and greater substrate metabolism in trained individuals have been found to be associated with 
greater respiratory capacity [Hawley et al., 2002]. In addition, it has been established that training 
stimulates an increase in mitochondrial content and function in skeletal muscle [Russel et al., 
2014].  To date, little is known about the effects of a long-term exercise programme on vascular 
mitochondria. Given the established relationship between exercise and augmented mitochondrial 
bioenergetics of cardiac and skeletal muscle, it is possible that similar benefits can also be observed 
in the vasculature. Thus, the present study used a novel approach to investigate how mitochondrial 
respiratory capacity of vascular smooth muscle cells in healthy subjects is affected by aerobic 
training.  
 
Materials and Methods  
Animal Care 
Healthy, age-matched (2-4 months) male C57BL/6 mice were obtained from the Concordia 
University breeding colony. Mice were individually housed in a 22°C room with a constant 12-
hour light/dark cycle and access to rodent chow and water. Mice were randomly assigned into two 
groups: Normal sedentary, which served as the controls (CON), and the Exercise group (EX). 
Measurements of body mass (g) as well as consumption of food (g) and water (ml) were obtained 
once a week. All procedures were approved by the Concordia University Animal Research Ethics 





Aerobic Exercise Intervention 
The EX group performed aerobic exercise three days a week for four weeks, for a total of twelve 
days. Exercise was carried out using an in-house built, customized,  graded rodent treadmill. The 
protocol consisted of two phases: acclimation and training. During acclimation (day one), mice 
were placed on the treadmill for three minutes to explore it [Bouganim and Bergdahl, 2017]. Next, 
the motor was turned on at zero speed for approximately two minutes to introduce the mice to the 
sounds of the treadmill [Bouganim and Bergdahl, 2017]. 
 
The training phase consisted of increasing the speed from 3, 5, 8 to 12 m/min at 0-2, 2-4, 4-6 and 
6-15 minutes respectively (Table 1). Each day, the session increased by 5 minutes (starting at 15 
minutes), until a total training time of 60 minutes was reached (day ten). For instance, mice were 
trained for 15 minutes on day one, followed by 20 minutes on day two, 25 minutes on day three, 
and so on. This pattern was maintained until the end of the protocol. To encourage mice to remain 
active on the treadmill, brushes were placed at the back of each lane to tickle their tails. When mice 
were unable to keep up with the treadmill, the exercise session was terminated. 
 




























Tissue permeabilization and preparation  
Mice were euthanized by CO2, after which aortic vessels were harvested and immediately stored 
in an ice-cold buffer solution (BIOPS) containing the following in mmol/L: CaK2EGTA 2.77, 
K2EGTA 7.23, Na2ATP 5.77, MgCl2·6H2O 6.56, taurine 20, phosphocreatine 15, imidazole 20, 
dithiothreitol 0.5, MES 50, pH 7.1 After removal of adventitial fat tissue, vessels were opened 
longitudinally and denuded of endothelium in ice-cold BIOPS buffer with a sponge. Tissues were 
then broken into smaller pieces and permeabilized in 2 ml BIOPS buffer containing 50μg/ml of 
saponin for 30 minutes, followed by two washes in 2 ml of ice-cold Mir05 buffer for 10 minutes 
each [Larsen et al., 2015]. Mir05 buffer contains (in mmol/L): EGTA 0.5, MgCl2·6H2O 3.0, K-
lactobionate 60, Taurine 20, KH2PO4 10, HEPES 20, sucrose 110, BSA 1g/l, pH 7.1. 
 
Measurements of mitochondrial respiration 
High-resolution respirometry was performed to quantify mitochondrial function using a 
polarographic oxygen sensor (Oxygraph-2k, Oroboros Instruments, Innsbruck, Austria). 
Permeabilized tissue (3-5 mg wet wt) were incubated in the Oxygraph chambers with 2 ml of Mir05 
buffer each and stirred continuously at 37 °C for 15-20 minutes to establish a baseline in the 
absence of respiratory substrates. Hyper-oxygenated conditions were maintained to prevent 
potential O2 diffusion limitations. Next, for each mitochondrial complex to be studied 
independently, the following substrates were injected sequentially in each chamber in accordance 
with the protocol described by Larsen et al. [2015]: malate (2 mmol/L); pyruvate (2 mmol/L); 
glutamate (10 mmol/L); ADP (5 mmol/L); 20 µl succinate (10 mmol/L) ; oligomycin (2 µg/ml) 
and antimycin A (2.5 µM) . The presence of malate + pyruvate + glutamate allowed for complex 
I, state 2 respiration to be examined, which represents the ADP-restricted, non-phosphorylating 
basal resting state. The addition of ADP allowed for complex I, state 3 to be analyzed, which 
provided an index of oxidative phosphorylation (OXPHOS). Succinate allowed for maximal state 
3 respiration to be achieved, with simultaneous activation of Complex I and Complex II. Finally, 
inhibitors oligomycin and antimycin A were injected to block Complexes V (LEAK) and III 
respectively. Respiration rates and O2 consumption were recorded and analyzed using the 
Oroboros DatLab software. In each condition, respiration rates were recorded for 3-5 minutes, with 




Immunoblotting and immunofluorescence  
Protein levels were assessed following the protocol described by Rocha et al. [2014]. Cell lysis of 
aortic vessels was performed in a lysis buffer containing (in mmol/L): NaCL 250, HEPES 50, 
glycerol 10%, Triton X-100 1%, MgCl2 1.5, EGTA 1, Na4P2O7 10, NaF 1, Na3VO4 800 µmol/L, 
pH 5. The solution was centrifuged for 10 minutes at 10,000 g, after which the supernatant was 
extracted. The Pierce BCA Protein Assay Kit (Thermo Scientific, Mississauga, Ontario, Canada) 
was used to assess protein levels with 10 µg of protein samples first separated on a 12.5% SDS-
PAGE and then transferred to a nitrocellulose membrane (0.45 µm, 162-0115, Bio-Rad) with 10 
mmol/L sodium tetraborate buffer. 5% BSA in TBS-T buffer (10 mmol/L Tris-HCL, pH 7.5, 150 
mmol/L NaCl, 0.05% Tween 20) was used to block the membranes for 1 hour at room temperature, 
followed by an overnight incubation period at 4 ºC with the antibody for voltage-dependent anion 
channel (VDAC; 1:1000, ab14734 Abcam) as well as total OXPHOS rodent antibody cocktail 
(1:500, MS604 MitoSciences). The resulting blots were washed and incubated with horseradish-
peroxidase-conjugated secondary antibodies (anti-mouse, ab6728 Abcam). Relative protein 
expression was visualized and studied using a chemiluminescence system (Immun-Star 
Chemiluminiscent, 1705070; Bio-Rad, Mississauga, Ontario, Canada) and bands analyzed with 
ImageJ software.  
 
Statistics 
Given the comparison between the DE and CON groups, a two-tailed Student’s t test was used for 
data analysis, where P < 0.05 was considered significant. Immunoblotting data and all other figures 















Immunoblotting using an antibody specific to the voltage-dependent anion channel (VDAC) was 
performed to control for differences in mitochondrial content between the EX and CON groups. 
The EX group displayed a non-significant increase in mitochondrial protein density compared to 




Figure 1: Immunoblots reveal that the EX group (n=10) exhibited an increase in mitochondrial 
density compared to CON (n=7) in response to a long-term, 4-week aerobic training programme 
(EX:135.99% ± 15.38% versus CON: 100%  ± 16.52%).  
 
Mitochondrial respiration  
To examine mitochondrial function and respiratory capacities, oxygen consumption rates of 
permeabilized tissues were measured via high resolution respirometry. OXPHOS capacity in the 
EX group were all significantly higher compared to CON following the addition of three different 
Complex I-linked, glucose-based substrates. Respiration rates after the injection of malate was 
higher in the EX group compared to CON (EX: 1.39 ± 0.23 versus CON: 0.80 ± 0.12, p<0.05 with 





























Weight, Food and Water Consumption  
Average consumption (Fig. 7) was calculated by subtracting weekly measurements from the 
previous week. Both EX and CON groups appeared to gain weight overall throughout the 
intervention, with the EX group gaining approximately 5.64% ± 1.88% of its’ baseline mass 
compared to 4.42% ± 2.06% in CON at the final weigh-in. Results indicate that CON group gained 
more weight overall when compared to EX, which is expected in sedentary models, except at week 
2 (EX 101.12% ± 1.67% versus CON: 98.33% ± 1.76%). CON group exhibited a weight increase 
at week 3, weighing approximately 104.34% compared to 100% at baseline, and continued to 
maintain that weight until the end of the intervention.   
 
 
Figure 7: Average weekly weight differences between EX and CON groups. Sedentary, CON 
animals gained more weight overall (except at week 2), signifying the positive correlation between 
physical inactivity and body mass. However, exercise also stimulated an increase in body mass, 
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Figure 9: Food consumption (g) was calculated by subtracting weekly measurements from 
previous week. No detectable differences in consumption between EX and CON were observed 
during weeks 1 and 2 (EX: 29.73 g ± 3.97 versus CON: 28.76 g ± 12.1 at during week 1 and EX: 
37.47 g ± 3.98 versus CON: 35.97 g ± 7.5 during week 2). However, CON appeared to have 
consumed the most food starting at week 3 until the end of the intervention with EX: 29.29 g ± 4.5 




Figure 10: Average water consumption was calculated by subtracting weekly measurements from 
the previous week. Results reveal that EX group consistently consumed more water throughout the 
4-week intervention when compared to CON. The largest difference occurred at the beginning of 



















































Exercise-induced mitochondrial adaptations include increased expression of mitochondrial 
subunits as well as improved oxidative/respiratory capacity that facilitate aerobic metabolism 
[Lundby and Jacobs, 2016]. Enhanced training performance is also determined by lower fatigue 
rates and greater substrate metabolism, which can be explained by measurements of mitochondrial 
density and relative protein levels. Evidence on the physiological adaptations of mitochondria in 
response to endurance training in skeletal and cardiac muscle are robust. Endothelial cells of the 
vasculature have an inherently low respiratory function, and vascular smooth muscle cells are ideal 
targets in studying mitochondrial respiration in the vasculature. To date, little is known about the 
exact impact of exercise on mitochondrial function and respiratory capacity of major blood vessels. 
Engaging in regular physical activity is a strong component for reducing the severity of 
cardiovascular risk factors, including obesity, dyslipidemia, hypertension, metabolic complications 
and atherosclerosis [Vanhees et al., 2011]. The purpose of this study was to examine oxidative 
capacity in healthy vascular tissue following a 4-week aerobic exercise programme.  
Relative increases in mitochondrial density and subsequent hypertrophy have been observed in 
skeletal muscle as a result of endurance exercise training, with a reported ∼40% increase in skeletal 
muscle [Montero et al., 2015]. Immunoblotting specific to VDAC in our study revealed that 
exercise training induced an increase in mitochondrial density in the EX group compared to CON, 
which is consistent with the trend reported in previous studies of skeletal and cardiac muscle. 
Exercise has also been found to stimulate important morphological changes such as an increase in 
mitochondrial protein expression [Hawley et al., 2002]. Our findings reflect this phenomenon 
where an overall upregulation of mitochondrial proteins in each complex (I-V) was observed in 
EX vessels compared to CON after training for 3 days/week for 4 weeks. Thus, these findings are 
in line with the premise that describes chronic adaptations as a result of the cumulative effects of 
repeated training sessions [Hawley et al., 2002].  
An increase in mitochondrial respiration was also an important finding of this study, with 
significance during Complex I specific respiration. The addition of malate lead to an increase in 
oxidative capacity in the EX compared to CON, signifying enhanced basal, ADP-restricted state 2 
respiration. Furthermore, significant increases in response to the addition of pyruvate and glutamate 
were also reported in EX vessels compared CON, which demonstrates augmented efficiency in 
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glucose metabolism during Complex I respiration as whole. This is further supported by the 
significant increase in the coupling of oxidation and phosphorylation during Complex I respiration 
observed in the EX group, as determined by the ACR. Recently, impairments in complex I activity 
has been strongly linked to Parkinson’s disease, type II diabetes and cardiovascular disease [Taylor 
et al. 2005]. Complex I is considered to be the most physiologically relevant complex in the 
electron transport chain as it is predominantly involved in energy metabolism. As a consequence, 
complex I directly contributes to excessive ROS production and oxidative stress, which are 
hallmark features of cardiovascular and metabolic disorders [Brownlee, 2005; Sharma et al. 2009]. 
Furthermore, maximal respiratory capacity was significantly increased in the EX vessels, as 
detected by the activation of succinate-stimulated complex I+II, state 3 respiration. This parameter 
can be compared to an athlete testing for VO2max and reflects the potential of the mitochondria to 
consume O2 during maximal Complex I+II respiration. The augmented OXPHOS capacity detected 
in the EX vessels following the addition of succinate implies that training had increased the 
maximal threshold of mitochondrial respiration when compared to CON, which can contribute to 
improved exercise performance.  
As illustrated in this study, long-term exercise has a clear and positive impact in Complex I 
respiration of EX vessels compared to CON, which is consistent with our hypothesis. This is 
important as deficiency of complex I is heavily implicated in mitochondrial dysfunction, ROS 
production and apoptosis programming [Brownlee, 2005; Sharma et al., 2009]. The ACR, as 
measured by the addition of the substrate ADP, was also significantly augmented in the EX group 
compared to CON. This finding indicates that the EX vessels has a higher 
oxidation:phosphorylation ratio, which compares maximal O2 consumption stimulated by ADP to 
basal respiration in the absence of ADP during Complex I activation. Indeed, as an adaptation to 
long-term endurance exercise, the EX vessels displayed enhanced ability to consume O2 based on 
ADP availability as a substrate for phosphorylation, and thus reflects the efficiency of ATP 
production. However, no detectable differences were observed in the respiratory control ratio 
(RCR) between both groups, indicating that the coupling between O2 consumption and oxidative 
phosphorylation for both complex I and II was unaffected in response to aerobic training. The RCR 
is described as the respiration rate in state 3 versus state 4, with higher values signifying greater 
mitochondrial capacity for substrate oxidation and subsequent ATP turnover as well as reduced 
proton leak [Brand, 2011]. Despite RCR representing a major part of mitochondria, it is not an 
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absolute method that is diagnostic of mitochondrial dysfunction. Therefore, with minimal 
differences in the RCR between EX and CON vessels, we can assume that Complex II may not be 
a limiting factor with regards to changes in mitochondrial respiration in response to exercise. 
Additionally, it could also indicate that vascular smooth muscle cell mitochondria do not inherently 
respond to exercise by increasing maximal O2 consumption (state 3 respiration), considering that 
blood vessels are involved mostly in mediating relatively minor increases in pulse pressure. As a 
comparison, the RCR in skeletal muscle mitochondria is generally expected to be higher in trained 
individuals compared to sedentary subjects, where an increase in state 3 to state 4 respiration would 
translate into an increase in maximal OXPHOS capacity to meet the greater metabolic demands of 
sustained skeletal muscle contractions during exercise.  
The relationship between food intake and exercise is complex and has been the focus of many 
research studies investigating lifestyle behaviours. In our project, EX mice did not exhibit 
significant changes in food intake throughout the intervention, with a decrease observed at week 
3. This finding is consistent with previous reports of decreased energy intake in male laboratory 
rats forced to run on treadmill [Titchenal, 1988]. Similarly, weekly food intake in the CON group 
did not change significantly, which was expected. The major difference is that sedentary CON 
mice, on average, consumed more food compared to EX mice over the course of 4 weeks. A 
possible explanation to this is a lack of stimuli, with feeding being the sole activity available to 
sedentary mice. Moreover, the CON group gained more weight overall (with the exception of week 
2) compared to EX, representing the positive correlation between physical inactivity and body 
mass. Finally, water consumption increased in the EX group compared to CON, which was 
expected given the higher water requirements following exercise exposure.  
 
Conclusion 
Mitochondrial dysfunction underlies the hallmark features of diabetes, obesity and vascular 
disease. The benefits of exercise in maintaining cardiovascular and metabolic health begin at the 
molecular level and stem from favourable physiological adaptations in the mitochondria. Increased 
mitochondrial network dynamics, electron transport activity, protein expression and energy 
metabolism in skeletal and cardiac muscle have all been previously reported to be determinants for 
enhanced training performance. Our study demonstrates that these adaptations extend to the 
vasculature, with a trend towards upregulation in mitochondrial subunits in complexes I-V as well 
30 
 
as mitochondrial density, with a significant increase in OXPHOS capacity during complex-I 
respiration of glucose-based substrates. Most notably, an increase in basal, ADP-restricted 
respiration was observed, as measured by the addition of malate, signifying augmented 
mitochondrial function during resting states. Indeed, the therapeutic implications of physical 
activity are substantial and treatments that target mitochondrial function can provide novel ways 


















   III 
Aerobic Training is Linked to Reduced Vascular 
Mitochondrial Respiratory Capacity in Type I 
Diabetes  
 

















Dana-Rae Reguis Yadao: preparation of manuscript, experimental techniques 
Andreas Bergdahl: editing of manuscript, experimental techniques 



















Cardiovascular disease continues to be the leading cause of morbidity and mortality in the diabetic 
population, with impaired mitochondrial function as a primary contributor to vascular 
complications. Lifestyle modifications such as rigorous diet and exercise are often the first steps to 
promote insulin sensitivity and cardiovascular health. Benefits of exercise have been heavily 
studied in both skeletal and cardiac muscle, with the effects on type II diabetes extended to type I. 
To date, little is known about the impact of aerobic training on mitochondrial oxidative capacity 
and respiration in the diabetic vasculature. The goal of this study was to examine the effects of a 
long-term aerobic exercise programme on mitochondrial function in the vessels of T1DM subjects. 
After induction of diabetes via peritoneal streptozotocin injection, male C57BL/6 mice were 
randomly assigned to either the diabetes control group (CON) or the diabetes and exercise group 
(DE) for 4 weeks. Aortic vessels were harvested and used for immunoblotting and high-resolution 
respirometry to study oxidative phosphorylation (OXPHOS) capacity. Our findings suggest that 
prolonged exercise induced a reduction in mitochondrial protein expression along all five 
complexes of the mitochondrial electron transport chain in the exercise group compared to 
sedentary counterparts. Moreover, non-significant changes in glucose-based substrate efficiency 
were observed, indicating that exercise did not stimulate enhanced mitochondrial dynamics in the 
vasculature with regards to Complex I. These findings are not consistent with the previously 
demonstrated advantages of exercise in healthy subjects, where mitochondrial biogenesis and 
increased efficiency are considered determinants of enhanced performance. As such, the precise 
mechanisms behind exercise training as a contributor to diabetes-related cardiovascular insults 









The global epidemic of diabetes is rapidly growing, with the prevalence expected to change the 
lives of approximately 439 million adults (aged 20-79) by 2030 [Shaw, 2009]. Of even greater 
concern is that this estimate does not consider that nearly 193 million individuals worldwide 
currently remain undiagnosed, consequently increasing their risk of developing severe 
complications related to untreated diabetes [American Diabetes Association, 2018]. Diabetes 
mellitus (DM) exists largely in two forms, Type I diabetes mellitus (T1DM) and Type II diabetes 
mellitus (T2DM). The former is characterized by an autoimmune process or a trauma leading to 
the destruction of pancreatic β-cells, and the latter, which represents most cases (90-95%), is caused 
by over-nutrition and a sedentary lifestyle [Sivitz and Yorek, 2009; Matough, 2012]. Despite 
differences in etiology, the ultimate consequences are chronic hyperglycemia [American Diabetes 
Association, 2010]. T1DM, however, is considered a greater health risk given that the disease 
develops early in life and is associated with long-term complications [Silverstein et al., 2005]. The 
emerging epidemic of diabetes largely contributes to the development of cardiovascular disease 
worldwide, with heart disease as the leading cause of death for both men and women [Pop et al., 
2015]. Diabetes is also closely related to the pathophysiology of dyslipidemia and obesity [Pop et 
al., 2015]. Additional pathological consequences include the failure of several organs, especially 
the eyes, kidneys, nerves, heart and blood vessels [Ceriello, 2003]. Pathways leading to the 
development of diabetes-specific complications of both the neuronal and vascular systems appear 
to be manifestations of mitochondrial dysfunction and subsequent oxidative damage [Brownlee, 
2005; Murphy et al., 2009].  
Mitochondria are important organelles that carry out several important tasks such as ROS 
generation, contractile function, calcium signaling and apoptosis programming [Knaub et al., 
2014]. However, its’ best-known role is the production of ATP, which is the energy required to 
sustain growth, metabolism and reproduction [Duchen, 2004]. ATP is produced through 
mitochondrial respiration, a process by which substrates, namely glucose-derived pyruvate, 
undergo a series of redox reactions in the tricarboxylic acid cycle to be reduced to NADH and 
FADH2, which then carry electrons to the respiratory chain through various protein complexes. 
[Duchen, 2004]. This process is accompanied by the simultaneous transfer of protons across the 
inner membrane outward, resulting in a potential difference, ultimately driving the synthesis of 
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ATP [Duchen, 2004]. Given the importance of these organelles in mediating nearly all cellular 
processes, strong emphasis is placed on understanding mitochondrial function and the pathogenic 
processes involved in various diseases, especially diabetes. Much work has already addressed the 
deleterious effects of diabetes on mitochondrial function in skeletal and cardiac muscle. For 
instance, oxidative stress is linked to mitochondrial alterations in skeletal muscle of both diet-
induced and streptozotocin (STZ)-treated diabetic mice, leading to impaired muscle force output, 
greater fatigue rates and reduced local blood flow [Kelley et al., 2002; Bergdahl et al., 2015]. STZ 
is commonly used in classical diabetes research as a drug to destroy pancreatic β-cells, thus 
resulting in an absolute deficiency in insulin and the development T1DM. Mitochondrial 
dysfunction and concomitant excessive ROS generation within cardiomyocytes were also found to 
be associated with structural changes of cardiac muscle, resulting in the progression of heart failure 
in diabetic patients [Boudina et al., 2010]. Regarding the vasculature, research has found that 
endothelial cells are particularly susceptible to hyperglycaemia-induced damage, with endothelial 
dysfunction considered as an early sign of impaired mitochondrial function [Tang, 2014].  
Significant reduction in the risk for cardiovascular disease is strongly associated with physical 
fitness, with exercise considered to be an effective prescription to regulate diabetes-related health 
issues. The benefits of regular physical activity on T2DM are firmly established, with significant 
improvements in insulin action as a major outcome [Colberg, 2010]. However, the risk for 
mitochondria-mediated vascular diseases remains significant, even in the presence of rigorous 
glycemic control, including diet and exercise.  
Studies examining mitochondrial bioenergetics in the vasculature of diabetic targets following 
physical activity have been challenging. As a consequence, the precise mechanisms underlying this 
process remain relatively unknown and cardiovascular disease continues to be the leading cause of 
mortality among diabetic patients. More importantly, past work has focused largely on T2DM, and 
thus little has been produced about the mitochondria in the vasculature of T1DM subjects. Given 
the demonstrated benefits of exercise, and that diabetes elicits serious vascular complications, we 
hypothesized that long-term aerobic training would elicit an increase in mitochondrial function in 







Age-matched (2-4 months) male C57BL/6 mice were obtained from the Concordia University 
breeding colony. Mice were individually housed in a 22°C room with a constant 12-hour light/dark 
cycle and access to rodent chow and water. Mice were randomly assigned into two groups for 4 
weeks:  Sedentary Diabetic (CON) and Diabetes with Exercise (DE). Diabetes was induced with a 
single injection (150 mg/kg) of streptozotocin (STZ) peritoneally. 1-2 days post-injection, blood 
glucose concentration was measured from the mouse-tail-vein using a glucometer (One Touch 
Verio Flex). A reading that exceeded 14 mmol/L was considered diabetic. Measurements of body 
mass (g) as well as consumption of food (g) and water (ml) were obtained once a week. All 
procedures were approved by the Concordia University Animal Research Ethics Committee and 
certified by the Canadian Council on Animal Care. 
 
Aerobic Exercise Intervention 
The DE group performed aerobic exercise three days a week for four weeks, for a total of twelve 
days. Exercise was carried out using an in-house built, customized, graded rodent treadmill. The 
protocol consisted of two phases: acclimation and training. During acclimation (day one), mice 
were placed on the treadmill for three minutes to explore it [Bouganim and Bergdahl, 2017]. Next, 
the motor was turned on at zero speed for approximately two minutes to introduce the mice to the 
sounds of the treadmill [Bouganim and Bergdahl, 2017]. 
 
The training phase consisted of increasing the speed from 3, 5, 8 to 10 m/min at 0-4, 4-8, 8-12 and 
12-15 minutes respectively (Table 1). Each day, the session increased by 5 minutes (starting at 15 
minutes), until a total training time of 60 minutes was reached (day ten). For instance, mice were 
trained for 15 minutes on day one, followed by 20 minutes on day two, 25 minutes on day three, 
and so on. This intensity was maintained until the end of the protocol (day twelve). To encourage 
mice to remain active on the treadmill, brushes were placed at the back of each lane to tickle their 


















Tissue permeabilization and preparation  
Mice were euthanized by CO2, after which aortic vessels were harvested and immediately stored 
in an ice-cold buffer solution (BIOPS) containing the following in mmol/L: CaK2EGTA 2.77, 
K2EGTA 7.23, Na2ATP 5.77, MgCl2·6H2O 6.56, taurine 20, phosphocreatine 15, imidazole 20, 
dithiothreitol 0.5, MES 50, pH 7.1 After removal of adventitial fat tissue, vessels were opened 
longitudinally and denuded of endothelium in ice-cold BIOPS buffer with a sponge. Tissues were 
then broken into smaller pieces and permeabilized in 2 ml BIOPS buffer containing 50μg/ml of 
saponin for 30 minutes, followed by two washes in 2 ml of ice-cold Mir05 buffer for 10 minutes 
each [Larsen et al. 2015]. Mir05 buffer contains (in mmol/L): EGTA 0.5, MgCl2·6H2O 3.0, K-





Time (min) Speed (m/min) 
0 – 4  3 
4 – 8  5 
8 – 12  8 
12 – 15  10 
0 – 4  3 
4 – 8 5 
8 – 12  8 
12 – 15  12 





Measurements of mitochondrial respiration 
High-resolution respirometry was performed to quantify mitochondrial function using a 
polarographic oxygen sensor (Oxygraph-2k, Oroboros Instruments, Innsbruck, Austria). 
Permeabilized tissue (2-5 mg wet wt) were incubated in the Oxygraph chambers with 2 ml of Mir05 
buffer each and stirred continuously at 37 °C for 15-20 minutes to establish a baseline in the 
absence of respiratory substrates. Hyperoxygenated conditions were maintained to prevent 
potential O2 diffusion limitations. Next, for each mitochondrial complex to be studied 
independently, the following substrates were injected sequentially in each chamber in accordance 
with the protocol described by Larsen et al. [2015]: malate (2 mmol/L); pyruvate; glutamate (10 
mmol/L); ADP (5 mmol/L); 20 µl succinate (10 mmol/L) ; oligomycin (2 µg/ml) and antimycin A 
(2.5 µM) . The presence of malate + pyruvate + glutamate allowed for complex I, state 2 respiration 
to be examined, which represents the ADP-restricted, non-phosphorylating basal resting state. The 
addition of ADP allowed for complex I, state 3 to be analyzed, which provided an index of 
oxidative phosphorylation (OXPHOS). Succinate allowed for maximal state 3 respiration to be 
achieved, with simultaneous activation of Complex I and Complex II. Finally, inhibitors 
oligomycin and antimycin A were injected to block Complexes V (LEAK) and III respectively. 
Respiration rates and O2 consumption were recorded and analyzed using the Oroboros DatLab 
software. In each condition, respiration rates were recorded for 3-5 minutes, with the average of 
the last minute used for data analysis.    
 
Immunoblotting and immunofluorescence  
Protein levels were assessed following the protocol described by Rocha et al. [2014]. Cell lysis of 
aortic vessels was performed in a lysis buffer containing (in mmol/L): NaCL 250, HEPES 50, 
glycerol 10%, Triton X-100 1%, MgCl2 1.5, EGTA 1, Na4P2O7 10, NaF 1, Na3VO4 800 µmol/L, 
pH 5. The solution was centrifuged for 10 minutes at 10,000 g, after which the supernatant was 
extracted. The Pierce BCA Protein Assay Kit (Thermo Scientific, Mississauga, Ontario, Canada) 
was used to assess protein levels with 10 µg of protein samples first separated on a 12.5% SDS-
PAGE and then transferred to a nitrocellulose membrane (0.45 µm, 162-0115, Bio-Rad) with 10 
mmol/L sodium tetraborate buffer. 5% BSA in TBS-T buffer (10 mmol/L Tris-HCL, pH 7.5, 150 
mmol/L NaCl, 0.05% Tween 20) was used to block the membranes for 1 hour at room temperature, 
followed by an overnight incubation period at 4 ºC with the antibody for voltage-dependent anion 
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channel (VDAC; 1:1000, ab14734 Abcam) as well as total OXPHOS rodent antibody cocktail 
(1:500, MS604 MitoSciences). The resulting blots were washed and incubated with horseradish-
peroxidase-conjugated secondary antibodies (anti-mouse, ab6728 Abcam). Relative protein 
expression was visualized and studied using a chemiluminescence system (Immun-Star 
Chemiluminiscent, 1705070; Bio-Rad, Mississauga, Ontario, Canada) and bands analyzed with 
ImageJ software.  
 
Statistics 
Given the comparison between the DE and CON groups, a two-tailed Student’s t test was used for 
data analysis, where P < 0.05 was considered significant. Immunoblotting data and all other figures 
were presented as means ± SE.  
 
 
Results   
 
Mitochondrial density 
Immunoblotting using an antibody that targets the voltage-dependent anion channel (VDAC) was 
performed to control for differences in mitochondrial content between the DE and CON groups 
(Fig. 1). There were no significance differences in mitochondrial protein density indicating that 
mitochondrial content was similar between DE and CON groups after a 4-week intervention.  
 
Figure 1: A downregulation in 
mitochondrial density was observed 
in the DE group compared to CON 
after the aerobic exercise 
intervention (DE: 90.1% ± 32.4% 































Figure 5: Immunoblotting 
revealed a non-significant 
downward trend in the 
expression of mitochondrial 
subunits of DE vessels along all 
mitochondrial complexes (I-V), 
relative to the control, where n=9 
in the CON group and n=5 in the 
EX group.  
 
 
Weight, Food and Water Consumption 
Fig. 6 depicts weight measurements taken at each week. Mice belonging to the exercise group (DE) 
demonstrated, on average, a decrease in body mass throughout the intervention, dropping down 
dramatically to 90% compared to their baseline values at the final weigh-in. Diabetic controls 
appeared to gain weight until week 2, having achieved a 5% increase in mass. Thereafter, weight 
loss was observed in both groups at week 4, with DE weighing approximately 10% less than 




























Figure 6: Weight measurements 
(g) throughout the 4-week aerobic 
exercise intervention showed that 
the DE group consistently lost 
body mass. CON displayed a 
significant increase at week 2, a 
decrease towards baseline values 
at weeks 3 and 4 and finally 
weighing approximately 7% more 
at the final weigh-in compared to 
baseline. (n = 5 in DE and n = 9 
in CON).  
 
 
Fig. 7 illustrates food quantities (g) that were measured once a week, which allowed us to calculate 
weekly consumption by subtracting weekly values from those obtained in the previous week. An 
average increase in rodent chow consumption was observed in the DE group up until week 3, at 
which point consumption appeared to decrease slightly until the end of the intervention. CON mice 
also displayed an increase in food intake, with a dramatic reduction observed at week 3 and was 
maintained until the end of the intervention. Food intake in the DE group were consistently higher 
compared to CON, with significance observed during week 3 (DE: 63.05 g ± 4.73 versus CON: 
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Figure 7 : Average rodent chow consumption (g) on a weekly basis was calculated. An overall increase in 
food intake in the DE group was observed compared to CON. Similar intake patterns of the groups were 
displayed in weeks 1 and 2, with notable differences observed at weeks 3 and 4 between DE and controls.  
 
Water intake measurements revealed that the DE group consumed more water than controls, which 
was expected given the nature of the disease (i.e. polydipsia) and exercise exposure. No significant 
differences were reported between the groups, and Fig. 8 illustrates that both DE and controls had 
similar water intake patterns week-by-week, with higher amounts of water consumed at weeks 1 
and 2 (DE: 73.3 ml ± 4.9 versus CON: 59.1 ml ± 2.6 and DE: 71.9 ± 5.2 versus CON: 56.7 ± 3.5) 
and lower amounts consumed beginning at week 3 until week 4 (DE: 57.6 ± 10.9 versus CON: 48.4 





























Figure 8: Average water consumption (ml). An overall decrease in water consumption was 
observed throughout the course of the intervention in both groups compared to week 1. However, 
this figure illustrates that there was a similar drop in water intake at week 3 (DE: 57.1 ± 10.9 and 
CON: 48.4 ±  3.8) compared to previous weeks. DE g appeared to consistently consume more 
water each week compared to CON, with the largest difference in intake observed at week 2 (DE: 
71. 9 ±  5.2 versus CON: 56.7 ±  3.5).  
 
Mortality Rates  
Over the course of the research, the total number of mice randomly chosen for the DE group was 
n=45 and n=40 for CON. The number of deaths were reported each week in each group, which 
allowed us to calculate mortality rate, as illustrated in Fig. 9. Both groups followed a similar trend, 
in which mortality rates increased at weeks 2 and 3 and dropped down at week 4. However, the DE 
group experienced an overall greater morality rate, indicating a positive correlation between 
































Figure 9: High mortality rates were observed in both groups, however the DE group appeared to 
have a higher mortality rate overall, especially at week 2 in which 35% of the group died. The 
upward trend follows the increasing intensity of the exercise protocol up until week 3, after which 
both groups displayed a decrease in mortality rate. At the end of the research project, only n=5 in 
the DE group as well as n=9 in the CON group had survived for vascular tissue analysis of 
mitochondrial respiratory capacity, representing 11% of the total DE mice and 22.5% of the total 
CON mice from the beginning of the research.  
 
Discussion 
Physical activity is considered an effective prescription to treat and prevent a variety of illnesses 
including diabetes and cardiovascular disease. Indeed, exercise training has been shown to 
stimulate mitochondrial hypertrophy and biogenesis, which are key features of enhanced muscle 
oxidative capacity and performance [Taivassalo and Haller, 2004]. In the case of diabetes, where 
mitochondrial dysfunction is associated with reduced mitochondrial abundance in skeletal muscle, 
exercise has been established as a formidable non-pharmacological approach to help maintain 
optimal glycemic control by improving insulin sensitivity [Dela et al., 1995; Patti et al., 2003]. 
Exercise-induced glucose uptake has been shown to be maintained in insulin-resistant muscle and 
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muscle cell membrane and augmented glycolysis [Sylow et al. 2017]. To date, little work has been 
done to examine the effects of long-term endurance exercise on vascular mitochondrial function in 
T1DM models. In this study, we investigated the effects of a 4-week progressive aerobic exercise 
programme on vascular mitochondria. Specifically, we evaluated whether mitochondrial 
respiratory capacity was enhanced in T1DM mice following endurance exercise compared to their 
sedentary counterparts. 
 
Mitochondria are highly dynamic organelles that can adapt to various physiological stimuli, such 
as exercise [Bo et al. 2010]. The present study found that endurance training had no significant 
effect on mitochondrial density in the vasculature of the DE group compared to CON, as measured 
by VDAC-specific immunoblotting. This finding indicates that, despite the benefits demonstrated 
in our previous study, exercise induces a downregulation in mitochondrial protein expression in 
vascular smooth muscle cells. In addition, a reduction in the respiration of Complex I-linked, 
glucose-based substrates in the DE group was observed, which suggests that exercise did not 
promote an increase in glucose uptake in the vasculature. Glucose transport across the cell 
membrane is facilitated by proteins GLUT1 and GLUT4, with GLUT1 responsible for basal 
glucose transport [Bell et al., 1990]. Moreover, GLUT4 increases intracellular glucose levels in 
response to insulin and contractions [Marshall et al., 1993]. A previous study reported that high 
blood glucose levels lead to a decrease in GLUT1 protein expression in vascular smooth muscle 
cells [Giovanni et al., 2003]. This is consistent with our results in the DE vessels, and could signify 
that the decrease in the respiration of glucose-based substrates could be attributed to 
hyperglycemia-induced impairments of GLUT1 transport proteins. Moreover, while it is possible 
that training in the DE group stimulated GLUT4 activation via skeletal muscle contractions, the 
downregulation of GLUT1 transport proteins could have caused the overall decrease in Complex I 
respiration. However, the precise underpinnings of the relationship between glucose transport 
regulation and Complex I respiration in diabetic vessels should be studied further.  
Complex I is considered to be the centre of electron transport chain activity as it is predominantly 
involved in energy metabolism. As a consequence, a deficiency in complex I activity directly 
contributes to excessive ROS production and oxidative stress, which are hallmark features of 
cardiovascular and metabolic disorders [Brownlee, 2005; Sharma et al., 2009]. A shift in free fatty 
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acid oxidation to meet the greater metabolic demands of aerobic exercise could also be attributed 
to the decrease in Complex I respiration observed in our study. Indeed, the major finding in our 
experiment is that the exercise training administered to diabetic mice with already compromised 
mitochondrial function facilitated an even greater degree of impaired respiratory capacity with 
regards to complex I activity. It is important to note that this unexpected outcome is based on 
subjects with poorly regulated T1DM. As a consequence, a recommendation for future work on 
this experiment would be to investigate the effects of aerobic training in conjunction with insulin 
therapy on mitochondrial function of vascular smooth muscle cells. The addition of a diabetic 
exercise group undergoing insulin therapy could greatly change this outcome to a favorable one, 
where Complex I respiration of glucose-based substrates could potentially be enhanced.  
The RCR, which is a measurement of the coupling between O2 consumption and oxidative 
phosphorylation (state 3 over state 4 respiration), is an important index of respirometry. Generally, 
a higher RCR is indicative of normal mitochondrial respiratory function [Fernstrom et al., 2004]. 
One study suggested that a low RCR in trained mice is associated with cardiac mitochondrial 
damage, however, the reason for this remains to be elucidated. The present study demonstrated no 
change in RCR in the DE group compared to CON, suggesting that the coupling between O2 and 
oxidative phosphorylation was not a limiting factor in the compromised respiratory function 
observed in complex I. This outcome was similar to that found in our first study, and the same 
rationale could be used to explain why the RCR between CON and DE remained unchanged post-
intervention. Despite RCR representing a major part of mitochondria, it is not an absolute method 
that is diagnostic of mitochondrial dysfunction. Therefore, with minimal differences in the RCR 
between EX and CON vessels, we can assume that Complex II may not be heavily involved with 
regards to changes in mitochondrial respiration in response to exercise. Additionally, it could also 
indicate that vascular smooth muscle cell mitochondria do not inherently respond to exercise by 
increasing maximal O2 consumption (state 3 respiration), considering that blood vessels are 
involved mostly in mediating relatively minor increases in pulse pressure.  Indeed, more work 
needs to be done to investigate the association between a reduction in RCR in the vasculature of 




Mitochondrial adaptations in response to exercise depend on frequency, intensity, duration and 
type of exercise [Bo et al., 2010]. The present study elected to administer a progressive aerobic 
exercise programme to avoid the plateau phenomenon, and to facilitate optimal exercise-induced 
changes in mitochondrial network dynamics. Initially, the dose of exercise given to the DE group 
was identical to the programme created by Bouganim and Bergdahl, which was created for normal, 
non-diseased mice [2016]. However, it was found that the intensity and duration were too high for 
T1DM mice to follow as well as recover from, with early onset fatigue and cessation of 
participation on the treadmill as indicators of fatigue and lowered aerobic capacity. As such, we 
adjusted the exercise protocol to a lower intensity. Despite these modifications, mortality rate of 
the DE group was significantly higher than CON. The majority of DE mice (~89%) eventually 
succumbed to the metabolic complications associated with diabetes at approximately weeks 2 and 
3, thus explaining the difference in sample sizes between the groups (n = 5 in DE and n= 9 in 
CON). These findings are consistent with results of weekly body mass and food/water intake, with 
dramatic weight loss as well as lowered food/water consumption observed at weeks 3 and 4 
respectively. However, the DE group consumed more water overall compared to CON, 
demonstrating additional water requirements in response to exercise combined with polydipsia as 
a symptom of increased blood sugar concentration in the diabetic population [Siddiqui et al., 2011]. 
These outcomes are a clear indication of the severe clinical characteristics of diabetes, and in the 
context of our experiment, implies that exercise appeared to exacerbate diabetic symptoms.  
Fatigue is recognized as a hallmark characteristic of mitochondrial dysfunction. Indications of 
fatigue include a lack of energy and a greater recovery time following physical activity [Rosenthal 
et al., 2008]. However, the proper clinical definition of fatigue with regards to mitochondrial 
function and diabetes are unclear. As such, fatigue in our study was deemed significant based on 
three different qualitative behavioural observations in both DE and CON groups: (1) inability to 
keep pace on the treadmill (DE only); (2) reduced self-grooming activity and (3) decreased nesting 
patterns. DE mice unable to maintain treadmill activity during the exercise session signified 
exhaustion and diminished endurance, which appeared to extend to resting states. Self-grooming 
in rodents is an inherent, often compulsive behaviour that involves a patterned, sequential 
organization important for hygiene maintenance [Spruijt et al., 1988]. During our experiment, 
diabetic mice exhibited abnormal self-grooming habits in the form of unkempt and sparse fur, 
compared to normal disease-free mice, who typically had flat and shiny coats. Furthermore, we 
50 
 
observed a discontinuation of nest building in diabetic mice, beginning at week 2 until the end of 
the 4-week intervention. This aberrant behaviour was important because nesting is strongly 
genetically determined in mice and allows for the maintenance of cage micro-climate factors such 
as temperature, light intensity and the ability to hide [Van Oortmerssen, 1971]. These observations 
could signify a compensatory mechanism in diabetic mice to conserve energy for more 
physiologically relevant processes such as homeostasis during metabolically compromised states 
and are consistent with our results of mortality rates. 
While high exhaustion and mortality rates created setbacks in the progression of our experiments, 
it ultimately provided qualitative evidence to support our findings that exercise has the ability to 
negatively affect vascular mitochondria during poorly regulated T1DM, and perhaps lead to the 
accelerated pathogenesis of cardiovascular complications. This unexpected observation is 
important as it negates all previously demonstrated benefits of exercise, such as those reported in 
our initial study, even when the intensity is significantly reduced. The cause of death could possibly 
be explained by mitochondrial dysfunction-mediated characteristics of heart disease, including 
atherosclerosis, hypertension and subsequent risk for aneurisms and heart attacks [Cerellio, 2003]. 
Furthermore, the use of streptozotocin as a means to induce diabetes could have led to multi-organ 
damage, secondary to the pancreas. While the drug is known to specifically target the pancreatic 
β-cells, its’ potential toxic effects on other tissues should also be examined. As such, more work 
needs to be done to explore the precise mechanisms behind the high mortality rate and whether 
cardiovascular insults or the administration of streptozotocin were directly associated with the 
deaths. More importantly, further investigation is required to determine the intensity and duration 










The relationship between regular exercise, unregulated TIDM and cardiovascular risk should be 
interpreted carefully. While positive physiological adaptations in the mitochondria have been 
reported in T2DM cases, the present study provides new evidence that aerobic training elicits no 
significantly positive changes in the vasculature of T1DM models and could potentially pose a risk 
to cardiovascular health. Furthermore, the role of streptozotocin could have played a major role in 
the high mortality rate, with evidence supporting its’ involvement in the damage of multiple organs. 
Indeed, our results indicate that aerobic training is linked to a decrease in vascular mitochondrial 
function, seen in the reduction in complex I respiration, as well as a trend towards downregulation 
of mitochondrial proteins along all complexes (I-V). To gain a more comprehensive understanding 
of the relationship between T1DM and aerobic exercise on mitochondrial function, future studies 
would benefit in including a group of T1DM models that receive insulin therapy in conjunction 
with an exercise programme. With cardiovascular disease as the leading cause of death among 
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The Western diet (WD) is defined as the high
intake of calories, saturated fats and sugars,
and has been linked with the alarming
increase of obesity and Type 2 diabetes
(T2D) in North America and Europe.
Chronic consumption of the Western diet
induces obesity, which originates as a
positive energy balance and subsequent
disruption of regulatory and metabolic
processes leading to excess fat mass. T2D
is characterized by insulin resistance, which
results in the abnormal cellular uptake of
carbohydrates and lipids. Ramifications of
insulin resistance include hyperglycaemia,
dyslipidaemia and oxidative stress. While
caloric restriction has been considered an
effective strategy for shedding excess weight
and restoring metabolic function, many
patients find it difficult to implement as
a long-term solution. Recent studies have
highlighted a different approach towards
weight loss and metabolic health, one
exclusively through the modification of
protein composition.
Dietary proteins generally have an
insulinotropic effect, consequently leading
to the increased uptake of glucose and sub-
sequent glycaemic control (Rietman et al.
2014). However, long-term consumption
of a high-protein (HP) diet is correlated
with a greater risk of developing conditions
related to metabolic dysfunction. Recent
observational and experimental evidence
suggest that excessive consumption of a
prominent group of amino acids (AAs), the
branched-chain AAs (BCAAs), may elicit
insulin resistance and glucose intolerance
(Chen &Yang, 2015). Proteins are composed
of both essential and non-essential AAs,
with the three BCAAs – leucine, iso-
leucine and valine – constituting up to 20%
of total dietary protein intake (Chen &
Yang, 2015). Augmented levels of BCAAs
have garnered much research attention as
potential biomarkers of T2D and obesity
(Rietman et al. 2014; Chen & Yang, 2015).
Greater BCAA serum levels obtained from a
HP diet result in poor insulin action and
increased mortality in both rodents and
humans, whereas a low-protein (LP) diet
promotes metabolic health via enhanced
insulin sensitivity as well as lower white
adipose tissue (WAT) mass (Fontana et al.
2016). Additionally, it was found that
a reduction in BCAA content can elicit
positive metabolic effects similar to a
normal LP diet (Fontana et al. 2016).
Consequently, the potential to alter the
pathophysiology of metabolic conditions
through the specific modification of dietary
proteins merits further investigation.
In a recent article published in The
Journal of Physiology, Cummings et al.
(2018) effectively filled this gap and
helped to further our overall under-
standing of the positive correlation
between augmented BCAA serum levels
and metabolic dysfunction. Specifically,
the authors challenged this relationship
by determining whether mice already
conditioned with obesity could achieve
restored metabolic health in less than
4 weeks after switching from a high-fat
Western diet to either a LP or a low-BCAA
diet. A reduction in adiposity, lowered
insulin resistance, adequate glycaemic
control and greater energy expenditure
(EE) served as indicators for over-
all metabolic health. Mice underwent
diet-induced obesity (DIO) through the
consumption of a WD for 12 weeks and
were then randomized into one of five
experimental groups: Control AA, ExLow
AA (contains a formulation of AAs that
are all significantly lower than the Control
AA diet), ExLow BCAA (specifically has
lowered amounts of L-Isoleucine, L-Leucine
and L-Valine compared to the Control AA
diet (Table 1, Cummings et al. 2018)), WD
supplemented with BCAAs, or WD. All
diets contained the same energy density
and macronutrient composition as typical
rodent chow. Body composition, EE, activity
levels and thickness of dermal white
adipose tissue (dWAT) were noted over a
period of 15 weeks. The two WD groups
continued to gain weight throughout the
intervention while the ExLow AA and
ExLow BCAA groups sustained rapid
weight loss. Moreover, the ExLow AA
group lost 25% of their body weight in
2 weeks and later settled at a lower weight
compared to non-WD mice. Control AA
mice normalized their weight but at a
much slower pace, which required two
additional months. Glucose tolerance and
insulin sensitivity improved in all normal
calorie diets compared to the WD group.
However, ExLow BCAA and ExLow AA diets
exhibited better glucose tolerance relative
to all groups, and ExLow AA displayed the
greatest correction with regards to insulin
sensitivity. Interestingly, the experienced
weight loss was not due to calorie restriction,
but rather from a LP and low AA diet which
subsequently increased EE, as confirmed
via indirect calorimetry (P < 0.05). All
DIO mice that were switched to a non-WD
had thinner dWAT measurements (ExLow
BCAA specifically), whereas DIO mice on
the WD or WD + BCAAs demonstrated
larger fat droplets.
To further verify the relationship between
decreased BCAAs and energy balance in
DIO mice, Cummings et al. created an
additional series of WDs, each with varying
levels of BCAAs. DIO mice were placed into
one of four groups: WD Control AA, WD
High BCAAs, WD Low BCAAs and WD Low
AAs. Similar results were found wherein
both WD Low BCAA and WD Low AA
groups lost weight progressively for 3 weeks
and restored their glycaemic control. No
difference in spontaneous activity among
all groups was noted, which indicates that
the weight loss was due to augmented EE
(P < 0.05). Further examination of the
increased EE following the WD Low AA and
WD Low BCAA diets revealed that fibroblast
growth factor 21 (FGF21) blood levels were
transiently elevated in the 12 days post-diet
switch from DIO. FGF21 is a hormone that
assists with energy balance regulation and
appears to be responsible for the boost in
EE. The mechanism involves the uncoupling
of UCP1 through the sympathetic nervous
system, thus establishing the connection
between FGF21 and the browning of WAT,
as well as the increased activation of
brown adipose tissue (BAT), which causes
the expression of mitochondrial-dense
multicellular adipocytes within the WAT
(Douris et al. 2015). These ‘beige’ spots are
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very metabolically active, and thus allow for
WAT to act in the same capacity as BAT
(Douris et al. 2015). Consequently, a rise in
EE is coupled with the loss of adipose mass
– consistent with the weight loss seen in the
WD Low BCAA and WD Low AA mice.
Previous work on this phenomenon
has already suggested that reducing the
protein:carbohydrate ratio mediates the
augmentation of FGF21 levels (Solon-Biet
et al. 2016). Indeed, Cummings et al. found
that a WD containing a physiologically
relevant 67% less BCAAs can temporarily
induce FGF21, which consequently lead
to the sustained increase in EE observed
in DIO mice. As such, this novel finding
demonstrates that selective AA reduction
can directly promote metabolic health
through an enhanced energy balance.
Therefore, in conducting a secondary
analysis of EE in groups fed with WDs
of varying BCAA levels, and implementing
precise physiological measures to test the
hypothesis, the methods employed by
Cummings et al. represent a complex
and comprehensive in vivo study. Taking
this into consideration, it is possible that
these findings can be applied to humans,
especially given that the relationship
between serum BCAAs and obesity has
already been established.
In conclusion, existing metabolic
dysfunctions resulting from a high-calorie,
high-fat and high-sugar WD can potentially
be reversed without caloric restriction.
Additionally, given that greater BCAA
serum levels have the potential to serve as
a biomarker for metabolic dysfunctions,
its detection in clinical settings should
be considered as it may contribute to
lowering the prevalence of obesity and
T2D. The Cummings et al. study also
highlights that both significant weight
loss and improved glycaemic control
observed in mice belonging to the WD
low BCAA group are likely a result of an
increase in EE. However, while the findings
are promising, more work needs to be
done to determine at what level of BCAA
manipulation and overall change in protein
quality can best elicit positive metabolic
effects and optimize EE in humans, and
whether this can be considered as a viable,
long-term solution for individuals suffering
from metabolic disorders. Moreover,
future research should address the FGF21
mechanism seen following BCAA restricted
diets in order to shed light on this specific
pathway, which includes how weight is lost
through the beiging of WAT and how UCP1
expression affects the process. To ascertain
what is precisely behind the shift in EE
will allow for a more realistic, translatable
weight loss alternative in humans. Thus,
by selectively moderating BCAA content,
whether through individualized diet plans
or eliciting AA-specific catabolism via
pharmaceutical measures, Cummings
et al. have revealed that it is possible to
reduce the complications associated with
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The objective of this thesis was to examine the effects of aerobic training on vascular mitochondrial 
respiration, with a follow-up investigation focusing on T1DM. Our research provides novel insight 
on how vascular mitochondrial respiratory capacity is affected by aerobic exercise and whether 
mitochondria-specific therapy could be used in the future to help reduce the risk of cardiovascular 
disease in T1DM patients.  
Mitochondria are dynamic organelles and highly adaptable to various physiological stimuli, 
including physical activity. Our results derived from healthy aortic vessels support this notion, with 
significant increases in complex I-linked, glucose-based substrate respiration and capacity as major 
findings. However, in the context of diabetes, the opposite was observed in which aerobic exercise 
appeared to induce a decrease in vascular mitochondrial complex I respiration, indicating that 
training has the potential to exacerbate mitochondria-mediated diabetic complications in the 
vasculature.  
Given the significant implications of mitochondrial dysfunction in the pathophysiology of diabetes, 
mitochondria-specific therapy may provide novel ways to treat the disease, or at least reduce the 
severity of complications associated with it. This project demonstrated that aerobic training led to 
a decrease in vascular mitochondrial content and function in poorly regulated T1DM models, and 
thus negated all previously demonstrated benefits of exercise. However, it is important to note that 
exercise is still important in maintaining a healthy lifestyle, and so more work needs to be done to 
investigate the exact dosage of aerobic training required to induce benefits in the vasculature of 
T1DM patients as a way to help reduce the risk of cardiovascular disease. Furthermore, it is 
important to determine the overall effects of the drug streptozotocin and its’ potential involvement 
in multi-system organ damage which could also explain the high mortality rate in the T1DM 
subjects of our study. In order to refine our understanding of the role of aerobic exercise and 
untreated T1DM on mitochondrial function, future long-term adjuvant studies should focus on 
investigating insulin therapy as well as different exercise parameters that best elicit positive 
mitochondrial adaptations. Consequently, new treatment strategies for diabetes are required to 
address both mitochondrial function and oxidative stress. Pharmacological interventions that target 
mitochondrial biogenesis and respiration have potential therapeutic importance, with antioxidant 
58 
 
molecules already garnering much research attention to effectively control ROS production and 
protect against oxidative damage in diabetes.  
Overall, this thesis contributes to potentially identifying novel methods to treat the metabolic and 
vascular complications of diabetes: from the specific modification of branched-chain amino acid 
intake in reducing the severity of T2DM to investigating the roles of aerobic exercise on 
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